WACHSTUMSHORMON-ENTHALTENDEPROTEINFORMULIERUNG

European patent · EP0587858 · Deleted

Register entry

Publication number
EP0587858
Application number
EP93908252
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Maintained in amended form
Filed
Apr 1, 1993
Published
Mar 23, 1994
Granted
Sep 6, 2000
Deleted
Apr 30, 2008
Reason
Annual fee unpaid
IPC classes
A61K 38/27 (2006.01)
A61K 47/12 (2006.01)
Priority
SE 9201073 03.04.1992
PCT application
PCT/SE1993/000281 01.04.1993
PCT publication
WO1993/019776 14.10.1993
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 24, 2024

    Corrected

    Published in Swissreg on 24.10.2024

  2. Nov 19, 2008

    Deleted, fee unpaid

    Published in Swissreg on 19.11.2008

  3. Jun 30, 2008

    Change

    Published in +pat+ No 12 in 2008

  4. Feb 29, 2008

    Address changed

    Owner
    Pharmacia & Upjohn Aktiebolag, 112 87 Stockholm, Sweden → Pfizer Health AB, Lindhagensgatan 133, 112 87 Stockholm, Sweden

    Published in +pat+ No 4 in 2008

  5. Dec 14, 2007

    Change

    Published in +pat+ No 23 in 2007

  6. Sep 15, 2000

    Granted

    Published in PIDTJ No 17 in 2000

  7. Sep 15, 2000

    Agent entered

    Representative
    Dietlin & Cie S.A., 15, rue du Mont-Blanc, 1201 Genève

    Published in PIDTJ No 17 in 2000

Parties

Holder

Pfizer Health AB

Lindhagensgatan 133, 112 87 Stockholm, SE

Agent

Dietlin & Cie S.A.

15, rue du Mont-Blanc, 1201 Genève

Inventor

CASTENSSON, Staffan

S-741 42 Knivsta, SE

FLORIN-ROBERTSSON, Ebba

S-113 27 Stockholm, SE

HÖKBY, Elvy

S-122 46 Enskede, SE

THOME, Sirkka

S-143 00 V rby, SE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.